Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: A prospective study

Journal of Clinical Oncology

Volumn 20, Issue 7, 2002, Pages 1775-1785

  Poon, Ronnie Tung Ping ^a   Ng, Irene Oi Lin ^a   Lau, Cecilia ^a   Yu, Wun Ching ^a   Yang, Zhen Fan ^a   Fan, Sheung Tat ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ANTIGENS, CD34; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0036534375     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.089     Document Type: Article

References (50)

1. What is the evidence that tumors are angiogenesis dependent?
2. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
3. Tumor angiogenesis
4. Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition
5. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
6. Intratumor microvessel density as a prognostic factor in cancer
7. Seminars in medicine of the Beth Israel Hospital, Boston: Clinical applications of research on angiogenesis
8. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
9. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
10. Vascular enumeration as a significant prognosticator for invasive breast carcinoma
11. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma
12. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer
13. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection
14. Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease
15. Extent of vascularization as a prognostic indicator in thin (<0.76mm) malignant melanomas
16. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
17. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
18. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma
19. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
20. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma
21. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance
22. Microvessel density of hepatocellular carcinoma: Its relationship with prognosis
23. Primary carcinoma of the liver: A study of 100 among 48,900 necropsies
24. Endothelial markers in malignant vascular turnouts of the liver: Superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin I
25. Immunoreactivity of sinusoids in hepatocellular carcinoma: An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34
26. Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma
27. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma
28. An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma
29. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: A study in 22 patients
30. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time: A preliminary report
31. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas
32. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis
33. Postoperative recurrence of hepatocellular carcinoma
34. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection
35. Hepatic resection for small hepatocellular carcinoma: The Queen Mary Hospital experience
36. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analysis
37. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas
38. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: With relation to tumor size and invasiveness
39. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
40. The clinical manipulation of angiogenesis: Pathology, side-effects, surprises and opportunities with novel human therapies
41. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma
42. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats
43. Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide
44. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
45. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
46. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor: A prospective randomized study of hepatitis C virus-related liver cancer
47. High-dose and long-term therapy with interferon-alpha inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential
48. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
49. Liver transplantation for hepatocellular carcinoma
50. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation